Hidefumi Nakamura

发表

The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure

Hidefumi Nakamura, M. Ishii, T. Sugimura, 1994, Clinical pharmacology and therapeutics.

The Current States, Challenges, Ongoing Efforts, and Future Perspectives of Pharmaceutical Excipients in Pediatric Patients in Each Country and Region

V. Patravale, Hidefumi Nakamura, S. Salunke, 2022, Children.

The selection and use of essential medicines.

Andy Gray, Sri Suryawati, S. Hill, 2008, World Health Organization technical report series.

The Selection and Use of Essential Medicines.

Andy Gray, Sri Suryawati, S. Hill, 2015, World Health Organization technical report series.

Role of Pharmacometrics in Drug Development in the Pediatric Population

I. Yano, Hidefumi Nakamura, T. Fukuda, 2016 .

Improvement of Pediatric Drug Development: Regulatory and Practical Frameworks.

Hidefumi Nakamura, D. Brasseur, N. Matsumaru, 2016, Clinical therapeutics.

Pharmacokinetics of Carboplatin in a One‐Year‐Old Anuric Boy Undergoing Hemodialysis and a Review of the Literature

S. Ito, Hidefumi Nakamura, C. Kiyotani, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab

K. Nakanishi, S. Ito, T. Morimoto, 2017, Pediatric Nephrology.

Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study)

Y. Ohashi, K. Nakanishi, S. Ito, 2018, Pediatric Nephrology.

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)

K. Nakanishi, S. Ito, Hidefumi Nakamura, 2018, BMC Nephrology.

Drug development: The use of unlicensed/off-label medicines in pediatrics.

Hidefumi Nakamura, Y. Yamashiro, Jennifer H. Martin, 2012, Journal of pediatric gastroenterology and nutrition.

The Japanese Perspective

Hidefumi Nakamura, S. Ono, 2013 .

Rituximab for patients with nephrotic syndrome – Authors' reply

S. Ito, Hidefumi Nakamura, K. Nozu, 2015, The Lancet.

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

R. Mori, Y. Ohashi, K. Nakanishi, 2014, The Lancet.

Reply to Béranger et al., “Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children”

Hidefumi Nakamura, J. Saito, A. Yamatani, 2021, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients

Hidefumi Nakamura, J. Saito, A. Yamatani, 2020, Antimicrobial Agents and Chemotherapy.

Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants.

B. Meibohm, V. Biran, J. N. van den Anker, 2019, The Journal of antimicrobial chemotherapy.

Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants

Hidefumi Nakamura, J. Saito, A. Yamatani, 2022, Microbiology spectrum.

Stability of Hydrocortisone in Oral Powder Form Compounded for Pediatric Patients in Japan

T. Hanawa, Hidefumi Nakamura, J. Saito, 2021, Pharmaceutics.

The status of paediatric medicines initiatives around the world—what has happened and what has not?

G. Kearns, G. Anabwani, Hidefumi Nakamura, 2011, European Journal of Clinical Pharmacology.

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment

E. Ota, R. Mori, S. Ito, 2014, Kidney international.

Effect of food on the pharmacokinetics and therapeutic efficacy of 4-phenylbutyrate in progressive familial intrahepatic cholestasis

H. Kusuhara, Y. Zen, Toshiaki Shimizu, 2019, Scientific Reports.

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)

K. Nakanishi, S. Ito, N. Yoshikawa, 2018, BMC Nephrology.

Pharmacokinetics of the H2 Blocker Roxatidine Acetate Hydrochloride in Pediatric Patients, in Comparison with Healthy Adult Volunteers

Hidefumi Nakamura, H. Kawashima, K. Nagao, 2012 .

Stability of clonidine hydrochloride in an oral powder form compounded for pediatric patients in Japan

T. Hanawa, Hidefumi Nakamura, J. Saito, 2021, Journal of pharmaceutical health care and sciences.

The status of paediatric medicines initiatives around the world—what has happened and what has not?

G. Kearns, G. Anabwani, Hidefumi Nakamura, 2011, European Journal of Clinical Pharmacology.

Retrospective survey of compounded medications for children in Japan.

Hidefumi Nakamura, J. Saito, A. Yamatani, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Oral Drug Compounding in Pediatric Patients: a Japanese Perspective

Hidefumi Nakamura, J. Saito, A. Yamatani, 2019, Journal of Pharmacology & Pharmaceutical Research.

Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research

Yasuhiro Suzuki, M. Kubota, E. Inoue, 2018, Journal of Neurology.

Comparative acceptability of mini-tablets, fine granules, and liquid formulations in young children: An exploratory randomized crossover study

S. Yamashita, K. Miyazaki, Hidefumi Nakamura, 2022, Journal of Drug Delivery Science and Technology.

Swallowability of Minitablets among Children Aged 6–23 Months: An Exploratory, Randomized Crossover Study

K. Miyazaki, Hidefumi Nakamura, J. Saito, 2022, Pharmaceutics.

How do Japanese children take their medicines, and what are pharmacists and paediatricians doing about it?

Hidefumi Nakamura, Yoichi Ishikawa, 2014, International journal of pharmaceutics.

Potentially Harmful Excipients in Neonatal Medications: An Observational and Cross-Regional Comparison of Japan and Europe

Hidefumi Nakamura, J. Saito, A. Yamatani, 2018 .

Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials.

L. Fabbri, R. Portman, J. Davis, 2019, The Journal of pediatrics.

Pediatric Pharmacology in Japan

Hidefumi Nakamura, S. Ito, Tohru Kobayashi, 2012, Pediatric Drugs.

Acute Encephalopathy Due to Aluminum Toxicity Successfully Treated by Combined Intravenous Deferoxamine and Hemodialysis

P. Rose, Hidefumi Nakamura, J. Blumer, 2000, Journal of clinical pharmacology.

Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome

K. Nakanishi, S. Ito, Hidefumi Nakamura, 2021, Journal of the American Society of Nephrology : JASN.

Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)

K. Nakanishi, Hidefumi Nakamura, T. Omori, 2019, BMC Nephrology.

Recommendations for HLA‐B*15:02 and HLA‐A*31:01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions

U. Amstutz, B. Carleton, M. Rieder, 2014, Epilepsia.

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.

Sudha R. Raman, Kenneth K C Man, E. Roughead, 2018, The lancet. Psychiatry.

Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan

H. Tsutsumi, S. Itoh, Hidefumi Nakamura, 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Low-dose l-isoproterenol versus salbutamol in hospitalized pediatric patients with severe acute exacerbation of asthma: A double-blind, randomized controlled trial.

Y. Ohashi, Y. Ohya, K. Akashi, 2019, Allergology international : official journal of the Japanese Society of Allergology.

Pemoline Ingestion in Children: A Report of Five Cases and Review of the Literature

Hidefumi Nakamura, J. Blumer, M. Reed, 2002, Journal of clinical pharmacology.

Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.

Y. Ohashi, K. Nakanishi, S. Ito, 2014, American Society of Nephrology. Clinical Journal.

Live attenuated vaccines under immunosuppressive agents or biological agents: survey and clinical data from Japan

Hidefumi Nakamura, T. Kawai, K. Shoji, 2021, European Journal of Pediatrics.

Current Aspects of Pediatric Pharmacokinetics and Pharmacodynamics of Antimicrobials in Japan: Importance of the Promotion of Population PK/PD Analysis

Hidefumi Nakamura, J. Saito, K. Shoji, 2022, The Pediatric infectious disease journal.

A Survey to Understand Parent/Caregiver and Children’s Views on Devices Used for the Administration of Oral Pediatric Medicines in Japan

J. Walsh, Hidefumi Nakamura, S. Salunke, 2022, Children.

Age-Appropriate Pediatric Dosage Forms in Japan: Insights into End-User Perceptions From an Observational Cross-Sectional Survey Assessing the Acceptability of Oral Formulation

M. Komura, Hidefumi Nakamura, J. Saito, 2019, Therapeutic innovation & regulatory science.

Meropenem pharmacokinetics during extracorporeal membrane oxygenation and continuous hemodialysis: A case report.

E. Capparelli, Hidefumi Nakamura, J. Saito, 2020, Journal of global antimicrobial resistance.

Facilitation of Paediatric Research in Japan

Hidefumi Nakamura, M. Ozaki, 2010 .

Principles of ethical consideration required for clinical research involving children

Hidefumi Nakamura, K. Matsui, Shimon Tashiro, 2021, Pediatrics international : official journal of the Japan Pediatric Society.

[Guidelines for the treatment of childhood IgA nephropathy].

K. Nakanishi, N. Yoshikawa, Hidefumi Nakamura, 2008, Nihon Jinzo Gakkai shi.

Drug-drug interactions in pediatric psychopharmacology.

Hidefumi Nakamura, M. Reed, A. P. Ten Eick, 1998, Pediatric clinics of North America.

The selection and use of essential medicines.

S. Hill, G. Kearns, A. Irs, 2008 .

Safety of oseltamivir in infants less than one year old: Prospective surveillance during the 2004–2005 influenza season in Japan

S. Itoh, Hidefumi Nakamura, K. Mitamura, 2013, Journal of Pediatric Infectious Diseases.

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

R. Mori, Y. Ohashi, K. Nakanishi, 2014, The Lancet.

Recommendations for HLA‐B*15:02 and HLA‐A*31:01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions

U. Amstutz, B. Carleton, M. Rieder, 2014, Epilepsia.

Modified pulmonary index score was sufficiently reliable to assess the severity of acute asthma exacerbations in children.

Y. Ohya, A. Ishiguro, Hidefumi Nakamura, 2014, Allergology international : official journal of the Japanese Society of Allergology.